S&P/TSX Composite Index Ends 0.30% Higher at 21871.96 — Data Talk
The S&P/TSX Composite Index is up 64.59 points or 0.30% today to 21871.96
--Up for four consecutive trading days
--Up 229.09 points or 1.06% over the last four trading days
--Largest four-day point and percentage gain since Tuesday, April 9, 2024
--Longest winning streak since Tuesday, Jan. 30, 2024, when the market rose for four straight trading days
--Off 2.19% from its record close of 22361.78 hit Tuesday, April 9, 2024
--Highest closing value since Friday, April 12, 2024
--Off 2.19% from its 52-week high of 22361.78 hit Tuesday, April 9, 2024
--Up 16.73% from its 52-week low of 18737.39 hit Friday, Oct. 27, 2023
--Rose 5.78% from 52 weeks ago
--Off 2.19% from its 2024 closing high of 22361.78 hit Tuesday, April 9, 2024
--Up 6.25% from its 2024 closing low of 20584.97 hit Tuesday, Feb. 13, 2024
--Month-to-date it is down 1.33%
--Year-to-date it is up 913.52 points or 4.36%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 22, 2024 17:13 ET (21:13 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?